22nd Aug 2018 12:49
LONDON (Alliance News) - Hikma Pharmaceuticals PLC said Chief Strategy & Corporate Development Officer Bassam Kanaan sold 30,000 shares at a price of 1,917 pence per share on Tuesday.
It has not been disclosed how many shares Kanaan now holds in the FTSE 250-listed pharmaceutical company following the GBP575,100 deal.
Shares in Hikma were trading down 0.7% at 1,934.50 pence each on Wednesday.
Related Shares:
Hikma Pharmaceuticals